Payer
Regional partnerships of NHS, academia and industry representatives will be invited to submit a bid to establish a Digital Innovation Hub in 2019.
The "historic changes" announced late yesterday by the Centers for Medicare & Medicaid Services, promising big adjustments to its policies around the Physician Fee Schedule and the Quality Payment Program, already have the healthcare industry talking.
Key Benefit Administrators (KBA), an Illinois-based administrator of self-funded employee welfare benefit plans for enterprises, has brought a lawsuit against Teladoc alleging a breach in obligations, pecuniary loss, defamation, and tortious interference all stemming from $450,000 in overcharges.
The Centers for Medicare and Medicaid Services released its new proposed Physician Fee Schedule and Qualified Payment Program updates for 2019, and the announcement includes some big strides forward in promoting digital health technology, including widened telemedicine coverage, an overhaul of documentation requirements, and a new focus on interoperability.
Healthcare data platform company Innovaccer has launched ACO Advisor, a new free online tool that uses publicly available data to advise Accountable Care Organizations on how to reduce costs and increase revenues.
In 2016, UnitedHealthcare and Medtronic cut a deal that established the latter’s devices as the preferred insulin pumps for United members with diabetes.
WellDoc has expanded its BlueStar digital diabetes management platform to include a weight loss feature and a feature for those with both diabetes and hypertension.
This quarter saw a handful of digital health stories regarding payers and their new digital offerings, especially in the area of diabetes care.
Health Secretary Jeremy Hunt trails new NHS patient app that will feature GP record access, appointment booking, and data-sharing preferences.
Healthy Interactions, a population health company that offers both digital and in-person programs for chronic disease management and education, announced last week that it has added two new programs, for cardiovascular disease and depression, to its portfolio.